Septerna Inc. (SEPN)
SEPN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$36.41
-3.05% on the day
Market cap
$1.7B
Small cap
Revenue · 2025
$46.0M
+4174.5% on 2024
Net income · 2025
-$48.9M
-106.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SEPN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001984086 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $46.0M |
| Net income | -$48.9M |
| Operating income | -$68.3M |
| Net margin | -106.4% |
| Operating margin | -148.6% |
| Revenue growth | +4174.5% |
| Cash | $120.7M |
| Total assets | $596.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 37.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-03-10 |
| Latest annual report | 10-K | 2026-03-09 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-08-25 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 168 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.4% |
| 1 month | -6.9% |
| 3 months | +14.6% |
| Year to date | +29.7% |
| 1 year | +50.1% |
| From 52-week high | -25.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MRVI | Maravai LifeSciences Holdings Inc. | $6.53 | -7.51% | $1.7B |
| BHVN | Biohaven Ltd. Common Shares | $11.42 | -3.30% | $1.7B |
| BRVE | Braveheart Bio Inc. | $19.33 | -5.06% | $1.7B |
| NUVB | Nuvation Bio Inc. | $4.72 | -3.67% | $1.7B |
| SRPT | Sarepta Therapeutics Inc. Common Stock (DE) | $16.51 | -5.33% | $1.7B |
| XNCR | Xencor Inc. | $23.52 | -6.07% | $1.7B |
| TRVI | Trevi Therapeutics Inc. | $12.29 | -4.95% | $1.8B |
| ZBIO | Zenas BioPharma Inc. | $25.16 | -4.70% | $1.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier